María Luz Amador Muñoz

María Luz Amador Muñoz

Auto-generated profile, based on publicly available information

María Luz Amador Muñoz

Asociación Española Contra el Cáncer, Teniente Coronel Noreña, 30, 28045 Madrid, Spain

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 September 2023 in Healthcare
Verified
Journal Article
Open access
PDF file
MSMario López Salas
Mario López Salas
DGDiego De Haro Gázquez
Diego De Haro Gázquez
BSBelén Fernández Sánchez
Belén Fernández Sánchez
MMMaría Luz Amador Muñoz
María Luz Amador Muñoz
In Spain, inequities exist in implementing colorectal cancer (CRC) tests with the target population—adults aged 50 to 69—as part of population-based CRC screening programs. This research aims to further our understanding of the target population’s awareness, attitudes, and perceptions of these test-based screening programs. A survey was carried out using an online panel representative of the target population, with a sample collected from 5313 individuals. Data collection took place in June 2022. Descriptive and bivariate analyses were carried out using contingency tables, the Chi-square test, and Cramer’s V statistics. The sample was also segmented based on key variables. Finally, the results were analyzed using logistic regression. In the sample population, 62.5% had taken the fecal occult blood test (FOBT), 72.5% reported receiving the invitation letter to participate in the screening program, and 86.8% had prior knowledge of the FOBT. Noncompliance was mainly due to lack of symptoms (40%), non-receipt of invitation letters (39.7%), and forgetfulness or neglect (28.5%). On the contrary, receipt of the letter of invitation (OR 7.35, p < 0.01) and prior knowledge of FOBT (OR 6.32, p < 0.01) were the main variables that increased the probability of test uptake. Other significant variables included frequency of primary care visits (OR 1.71, p < 0.01) and being older (65–69 years old) (OR 1.52, p < 0.01) There is still a pressing need for greater awareness of both CRC risk factors and the benefits of early detection, as well as for overcoming the common misconception that detection should only be sought when symptoms are present.

25 October 2024 in Tobacco Induced Diseases
Verified
Journal Article
Open access
DHDiego de Haro
Diego de Haro
MAMaria Luz Amador
Maria Luz Amador
MSMario López Salas
Mario López Salas
KRKaren Ramirez
Karen Ramirez
AYAntonio Yanes-Roldan
Antonio Yanes-Roldan
Jose M Martin-MorenoJose M Martin-Moreno
Jose M Martin-Moreno
Introduction: Digital platforms serve as an avenue for the tobacco industry to promote both conventional tobacco and emerging products, with a notable focus on capturing the attention of young people through sophisticated marketing campaigns. This research aims to analyze the prevalence of...